Who Benefits from Aggressive Rapid Response System Treatments Near the End of Life? A Retrospective Cohort Study

Joint Commission Journal on Quality and Patient Safety
Magnolia CardonaKen Hillman

Abstract

Many patients near the end of life are subject to rapid response system (RRS) calls. A study was conducted in a large Sydney teaching hospital to identify a cutoff point that defines nonbeneficial treatment for older hospital patients receiving an RRS call, describe interventions administered, and measure the cost of hospitalization. This was a retrospective cohort of 733 adult inpatients with data for the period three months before and after their last placed RRS call. Subgroup analysis of patients aged ≥ 80 years was conducted. Log-rank, chi-square, and t-tests were used to compare survival, and logistic regression was used to examine predictors of death. Overall, 65 (8.9%) patients had a preexisting not-for-resuscitation (NFR) or not-for-RRS order; none of those patients survived to three months. By contrast, patients without an NFR or not-for-RRS order had three-month survival probability of 71% (log-rank χ2 145.63; p < 0.001). Compared with survivors, RRS recipients who died were more likely to be older, to be admitted to a medical ward, and to have a larger mean number of admissions before the RRS. The average cost of hospitalization for the very old transferred to the ICU was higher than for those not requiring treatment...Continue Reading

References

Jan 25, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Jennifer A WooTheodore A Stern
Aug 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJohn Z Ayanian
Oct 14, 2008·Intensive Care Medicine·Elie AzoulayUNKNOWN SAPS 3 investigators
Sep 16, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Rodrigo VazquezConstantine A Manthous
Jun 18, 2010·Annals of Emergency Medicine·Benjamin T SquireJoshua H Tamayo-Sarver
May 9, 2012·Journal of Medical Ethics·Ralf J JoxGian Domenico Borasio
Feb 5, 2013·Resuscitation·Charles CoventryTracey Cramey
Jul 17, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·John J YouUNKNOWN Canadian Researchers at the End of Life Network (CARENET)
Aug 31, 2013·Critical Care Medicine·Robert L SmithKevin Felner
Jan 9, 2014·The American Journal of Hospice & Palliative Care·Vasco Moscovici da CruzPedro Caruso
May 2, 2014·BMJ Supportive & Palliative Care·Catriona KennedySusie Chater
May 9, 2014·Critical Care Medicine·Thanh N HuynhNeil S Wenger
Jun 8, 2014·The American Journal of Hospice & Palliative Care·Paul E Marik
Sep 16, 2014·Current Opinion in Critical Care·Nita Khandelwal, J Randall Curtis
Oct 10, 2014·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Benjamin TamAlison Fox-Robichaud
Dec 4, 2014·Journal of Critical Care·John C O'HoroJeffrey B Jensen
Dec 5, 2014·Clinical Interventions in Aging·Graham EllisClaire Ritchie
Jun 10, 2015·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Carl van WalravenJacques Donzé
Jun 30, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·M Cardona-MorrellK Hillman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.